Why the study?
Does a steerable sheath improve single procedure success in patients with drug-refractory AF undergoing their first ablation procedure?
Does a steerable sheath improve single procedure success in patients with drug-refractory AF undergoing their first ablation procedure?
The use of a steerable sheath during atrial fibrillation catheter ablation significantly improves clinical success rates and reduces fluoroscopy time compared to a nonsteerable sheath.
Answers are grounded in this paper and cite their sources.
Steerable sheaths may improve first AF ablation success; extends RCT evidence for better rhythm outcomes.
BACKGROUND: Steerable sheath technology is designed to facilitate catheter access, stability, and tissue contact in target sites of atrial fibrillation (AF) catheter ablation. We hypothesized that rhythm control after interventional AF treatment is more successful using a steerable as compared with a nonsteerable sheath access. METHODS AND RESULTS: One hundred thirty patients with paroxysmal or persistent drug-refractory AF undergoing their first ablation procedure were prospectively included in a randomized fashion in 2 centers. Ablation was performed by 10 operators with different levels of clinical experience. Treatment outcome was measured with serial 7-day Holter ECGs and additional symptom-based arrhythmia documentation. Single procedure success (freedom from AF and/or atrial macroreentrant tachycardia) was significantly higher in patients ablated with a steerable sheath (78% versus 55% after 3 months, P=0.005; 76% versus 53% after 6 months, P=0.008). Rate of pulmonary vein isolation, procedure duration, and radiofrequency application time did not differ significantly, whereas fluoroscopy time was lower in the steerable sheath group (33±14 minutes versus 45±17 minutes, P<0.001). Complication rates showed no significant difference (3.2% versus 5%, P=0.608). On multivariable analysis, steerable sheath usage remained the only powerful predictor for rhythm outcome after 6 months of follow-up (hazard ratio, 2.837 [1.197 to 6.723]). CONCLUSIONS: AF catheter ablation using a manually controlled, steerable sheath for catheter navigation resulted in a significantly higher clinical success rate, with comparable complication rates and with a reduction in periprocedural fluoroscopy time. CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov. Unique identifier: NCT00469638.
No takes yet. Share an insight, caveat, or question.
Piorkowski et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: